SEC Form 4 · accession 0001683168-19-000025
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuichi Iwaki
Officer — President and CEO · Director
Period of report
Jan 3, 2019
Accepted (ET)
Jan 7, 2019 · 6:04 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2019 | M | 18,572 | $2.20 | A | 759,392 | D | |
| Common StockF2 | holding | — | — | — | 125,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $2.20 | Jan 3, 2019 | M | 18,572 | D | — | Jan 29, 2019 | Common Stock | 18,572 | 0 | D |
Explanation of responses
- F1Includes 226 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c).
- F2The reported securities are held by the Iwaki Family Limited Partnership. The reporting person is the general partner of the partnership that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3The option vested over a period of 4 years in equal monthly installments from the 1/30/2009 date of grant and is now fully vested.